Click for best price
CognitionEnhancing Drugs Market Size, Share 2023
Cognition-enhancing drugs are purported to improve mental functions such as cognition, memory, intelligence, motivation, attention and concentration.
This report aims to provide a comprehensive presentation of the global market for Cognition-Enhancing Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cognition-Enhancing Drugs. This report contains market size and forecasts of Cognition-Enhancing Drugs in global, including the following market information:
Global Cognition-Enhancing Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Cognition-Enhancing Drugs Market Sales, 2018-2023, 2024-2029, (K MT)
Global top five Cognition-Enhancing Drugs companies in 2022 (%)
The global Cognition-Enhancing Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Oral Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cognition-Enhancing Drugs include Accelerated Intelligence, Cognition Therapeutics, Cogstate, HVMN and Biogen Idec, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cognition-Enhancing Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cognition-Enhancing Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Cognition-Enhancing Drugs Market Segment Percentages, by Type, 2022 (%)
Oral
Injection
Global Cognition-Enhancing Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Cognition-Enhancing Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Drug Stores
Retail Pharmacies
Global Cognition-Enhancing Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Cognition-Enhancing Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cognition-Enhancing Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Cognition-Enhancing Drugs revenues share in global market, 2022 (%)
Key companies Cognition-Enhancing Drugs sales in global market, 2018-2023 (Estimated), (K MT)
Key companies Cognition-Enhancing Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Accelerated Intelligence
Cognition Therapeutics
Cogstate
HVMN
Biogen Idec
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cognition-Enhancing Drugs, market overview.
Chapter 2: Global Cognition-Enhancing Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Cognition-Enhancing Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cognition-Enhancing Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Cognition-Enhancing Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Cognition-Enhancing Drugs Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
72 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cognition-Enhancing Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cognition-Enhancing Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cognition-Enhancing Drugs Overall Market Size
2.1 Global Cognition-Enhancing Drugs Market Size: 2022 VS 2029
2.2 Global Cognition-Enhancing Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Cognition-Enhancing Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Cognition-Enhancing Drugs Players in Global Market
3.2 Top Global Cognition-Enhancing Drugs Companies Ranked by Revenue
3.3 Global Cognition-Enhancing Drugs Revenue by Companies
3.4 Global Cognition-Enhancing Drugs Sales by Companies
3.5 Global Cognition-Enhancing Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Cognition-Enhancing Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Cognition-Enhancing Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Cognition-Enhancing Drugs Players in Global Market
3.8.1 List of Global Tier 1 Cognition-Enhancing Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Cognition-Enhancing Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Cognition-Enhancing Drugs Market Size Markets, 2022 & 2029
4.1.2 Oral
4.1.3 Injection
4.2 By Type - Global Cognition-Enhancing Drugs Revenue & Forecasts
4.2.1 By Type - Global Cognition-Enhancing Drugs Revenue, 2018-2023
4.2.2 By Type - Global Cognition-Enhancing Drugs Revenue, 2024-2029
4.2.3 By Type - Global Cognition-Enhancing Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Cognition-Enhancing Drugs Sales & Forecasts
4.3.1 By Type - Global Cognition-Enhancing Drugs Sales, 2018-2023
4.3.2 By Type - Global Cognition-Enhancing Drugs Sales, 2024-2029
4.3.3 By Type - Global Cognition-Enhancing Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Cognition-Enhancing Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cognition-Enhancing Drugs Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Drug Stores
5.1.4 Retail Pharmacies
5.2 By Application - Global Cognition-Enhancing Drugs Revenue & Forecasts
5.2.1 By Application - Global Cognition-Enhancing Drugs Revenue, 2018-2023
5.2.2 By Application - Global Cognition-Enhancing Drugs Revenue, 2024-2029
5.2.3 By Application - Global Cognition-Enhancing Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Cognition-Enhancing Drugs Sales & Forecasts
5.3.1 By Application - Global Cognition-Enhancing Drugs Sales, 2018-2023
5.3.2 By Application - Global Cognition-Enhancing Drugs Sales, 2024-2029
5.3.3 By Application - Global Cognition-Enhancing Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Cognition-Enhancing Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Cognition-Enhancing Drugs Market Size, 2022 & 2029
6.2 By Region - Global Cognition-Enhancing Drugs Revenue & Forecasts
6.2.1 By Region - Global Cognition-Enhancing Drugs Revenue, 2018-2023
6.2.2 By Region - Global Cognition-Enhancing Drugs Revenue, 2024-2029
6.2.3 By Region - Global Cognition-Enhancing Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Cognition-Enhancing Drugs Sales & Forecasts
6.3.1 By Region - Global Cognition-Enhancing Drugs Sales, 2018-2023
6.3.2 By Region - Global Cognition-Enhancing Drugs Sales, 2024-2029
6.3.3 By Region - Global Cognition-Enhancing Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Cognition-Enhancing Drugs Revenue, 2018-2029
6.4.2 By Country - North America Cognition-Enhancing Drugs Sales, 2018-2029
6.4.3 US Cognition-Enhancing Drugs Market Size, 2018-2029
6.4.4 Canada Cognition-Enhancing Drugs Market Size, 2018-2029
6.4.5 Mexico Cognition-Enhancing Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Cognition-Enhancing Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Cognition-Enhancing Drugs Sales, 2018-2029
6.5.3 Germany Cognition-Enhancing Drugs Market Size, 2018-2029
6.5.4 France Cognition-Enhancing Drugs Market Size, 2018-2029
6.5.5 U.K. Cognition-Enhancing Drugs Market Size, 2018-2029
6.5.6 Italy Cognition-Enhancing Drugs Market Size, 2018-2029
6.5.7 Russia Cognition-Enhancing Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Cognition-Enhancing Drugs Market Size, 2018-2029
6.5.9 Benelux Cognition-Enhancing Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Cognition-Enhancing Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Cognition-Enhancing Drugs Sales, 2018-2029
6.6.3 China Cognition-Enhancing Drugs Market Size, 2018-2029
6.6.4 Japan Cognition-Enhancing Drugs Market Size, 2018-2029
6.6.5 South Korea Cognition-Enhancing Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Cognition-Enhancing Drugs Market Size, 2018-2029
6.6.7 India Cognition-Enhancing Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Cognition-Enhancing Drugs Revenue, 2018-2029
6.7.2 By Country - South America Cognition-Enhancing Drugs Sales, 2018-2029
6.7.3 Brazil Cognition-Enhancing Drugs Market Size, 2018-2029
6.7.4 Argentina Cognition-Enhancing Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Cognition-Enhancing Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Cognition-Enhancing Drugs Sales, 2018-2029
6.8.3 Turkey Cognition-Enhancing Drugs Market Size, 2018-2029
6.8.4 Israel Cognition-Enhancing Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Cognition-Enhancing Drugs Market Size, 2018-2029
6.8.6 UAE Cognition-Enhancing Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Accelerated Intelligence
7.1.1 Accelerated Intelligence Company Summary
7.1.2 Accelerated Intelligence Business Overview
7.1.3 Accelerated Intelligence Cognition-Enhancing Drugs Major Product Offerings
7.1.4 Accelerated Intelligence Cognition-Enhancing Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Accelerated Intelligence Key News & Latest Developments
7.2 Cognition Therapeutics
7.2.1 Cognition Therapeutics Company Summary
7.2.2 Cognition Therapeutics Business Overview
7.2.3 Cognition Therapeutics Cognition-Enhancing Drugs Major Product Offerings
7.2.4 Cognition Therapeutics Cognition-Enhancing Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Cognition Therapeutics Key News & Latest Developments
7.3 Cogstate
7.3.1 Cogstate Company Summary
7.3.2 Cogstate Business Overview
7.3.3 Cogstate Cognition-Enhancing Drugs Major Product Offerings
7.3.4 Cogstate Cognition-Enhancing Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Cogstate Key News & Latest Developments
7.4 HVMN
7.4.1 HVMN Company Summary
7.4.2 HVMN Business Overview
7.4.3 HVMN Cognition-Enhancing Drugs Major Product Offerings
7.4.4 HVMN Cognition-Enhancing Drugs Sales and Revenue in Global (2018-2023)
7.4.5 HVMN Key News & Latest Developments
7.5 Biogen Idec
7.5.1 Biogen Idec Company Summary
7.5.2 Biogen Idec Business Overview
7.5.3 Biogen Idec Cognition-Enhancing Drugs Major Product Offerings
7.5.4 Biogen Idec Cognition-Enhancing Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Biogen Idec Key News & Latest Developments
8 Global Cognition-Enhancing Drugs Production Capacity, Analysis
8.1 Global Cognition-Enhancing Drugs Production Capacity, 2018-2029
8.2 Cognition-Enhancing Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Cognition-Enhancing Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Cognition-Enhancing Drugs Supply Chain Analysis
10.1 Cognition-Enhancing Drugs Industry Value Chain
10.2 Cognition-Enhancing Drugs Upstream Market
10.3 Cognition-Enhancing Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Cognition-Enhancing Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Cognition-Enhancing Drugs in Global Market
Table 2. Top Cognition-Enhancing Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Cognition-Enhancing Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Cognition-Enhancing Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Cognition-Enhancing Drugs Sales by Companies, (K MT), 2018-2023
Table 6. Global Cognition-Enhancing Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Cognition-Enhancing Drugs Price (2018-2023) & (USD/MT)
Table 8. Global Manufacturers Cognition-Enhancing Drugs Product Type
Table 9. List of Global Tier 1 Cognition-Enhancing Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cognition-Enhancing Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cognition-Enhancing Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Cognition-Enhancing Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Cognition-Enhancing Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Cognition-Enhancing Drugs Sales (K MT), 2018-2023
Table 15. By Type - Global Cognition-Enhancing Drugs Sales (K MT), 2024-2029
Table 16. By Application ? Global Cognition-Enhancing Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Cognition-Enhancing Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Cognition-Enhancing Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Cognition-Enhancing Drugs Sales (K MT), 2018-2023
Table 20. By Application - Global Cognition-Enhancing Drugs Sales (K MT), 2024-2029
Table 21. By Region ? Global Cognition-Enhancing Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Cognition-Enhancing Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Cognition-Enhancing Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Cognition-Enhancing Drugs Sales (K MT), 2018-2023
Table 25. By Region - Global Cognition-Enhancing Drugs Sales (K MT), 2024-2029
Table 26. By Country - North America Cognition-Enhancing Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Cognition-Enhancing Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Cognition-Enhancing Drugs Sales, (K MT), 2018-2023
Table 29. By Country - North America Cognition-Enhancing Drugs Sales, (K MT), 2024-2029
Table 30. By Country - Europe Cognition-Enhancing Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Cognition-Enhancing Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Cognition-Enhancing Drugs Sales, (K MT), 2018-2023
Table 33. By Country - Europe Cognition-Enhancing Drugs Sales, (K MT), 2024-2029
Table 34. By Region - Asia Cognition-Enhancing Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Cognition-Enhancing Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Cognition-Enhancing Drugs Sales, (K MT), 2018-2023
Table 37. By Region - Asia Cognition-Enhancing Drugs Sales, (K MT), 2024-2029
Table 38. By Country - South America Cognition-Enhancing Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Cognition-Enhancing Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Cognition-Enhancing Drugs Sales, (K MT), 2018-2023
Table 41. By Country - South America Cognition-Enhancing Drugs Sales, (K MT), 2024-2029
Table 42. By Country - Middle East & Africa Cognition-Enhancing Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Cognition-Enhancing Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Cognition-Enhancing Drugs Sales, (K MT), 2018-2023
Table 45. By Country - Middle East & Africa Cognition-Enhancing Drugs Sales, (K MT), 2024-2029
Table 46. Accelerated Intelligence Company Summary
Table 47. Accelerated Intelligence Cognition-Enhancing Drugs Product Offerings
Table 48. Accelerated Intelligence Cognition-Enhancing Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 49. Accelerated Intelligence Key News & Latest Developments
Table 50. Cognition Therapeutics Company Summary
Table 51. Cognition Therapeutics Cognition-Enhancing Drugs Product Offerings
Table 52. Cognition Therapeutics Cognition-Enhancing Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 53. Cognition Therapeutics Key News & Latest Developments
Table 54. Cogstate Company Summary
Table 55. Cogstate Cognition-Enhancing Drugs Product Offerings
Table 56. Cogstate Cognition-Enhancing Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 57. Cogstate Key News & Latest Developments
Table 58. HVMN Company Summary
Table 59. HVMN Cognition-Enhancing Drugs Product Offerings
Table 60. HVMN Cognition-Enhancing Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 61. HVMN Key News & Latest Developments
Table 62. Biogen Idec Company Summary
Table 63. Biogen Idec Cognition-Enhancing Drugs Product Offerings
Table 64. Biogen Idec Cognition-Enhancing Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 65. Biogen Idec Key News & Latest Developments
Table 66. Cognition-Enhancing Drugs Production Capacity (K MT) of Key Manufacturers in Global Market, 2021-2023 (K MT)
Table 67. Global Cognition-Enhancing Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 68. Global Cognition-Enhancing Drugs Production by Region, 2018-2023 (K MT)
Table 69. Global Cognition-Enhancing Drugs Production by Region, 2024-2029 (K MT)
Table 70. Cognition-Enhancing Drugs Market Opportunities & Trends in Global Market
Table 71. Cognition-Enhancing Drugs Market Drivers in Global Market
Table 72. Cognition-Enhancing Drugs Market Restraints in Global Market
Table 73. Cognition-Enhancing Drugs Raw Materials
Table 74. Cognition-Enhancing Drugs Raw Materials Suppliers in Global Market
Table 75. Typical Cognition-Enhancing Drugs Downstream
Table 76. Cognition-Enhancing Drugs Downstream Clients in Global Market
Table 77. Cognition-Enhancing Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Cognition-Enhancing Drugs Segment by Type in 2022
Figure 2. Cognition-Enhancing Drugs Segment by Application in 2022
Figure 3. Global Cognition-Enhancing Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cognition-Enhancing Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Cognition-Enhancing Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Cognition-Enhancing Drugs Sales in Global Market: 2018-2029 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Cognition-Enhancing Drugs Revenue in 2022
Figure 9. By Type - Global Cognition-Enhancing Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Cognition-Enhancing Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Cognition-Enhancing Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Cognition-Enhancing Drugs Price (USD/MT), 2018-2029
Figure 13. By Application - Global Cognition-Enhancing Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Cognition-Enhancing Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Cognition-Enhancing Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Cognition-Enhancing Drugs Price (USD/MT), 2018-2029
Figure 17. By Region - Global Cognition-Enhancing Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Cognition-Enhancing Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Cognition-Enhancing Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Cognition-Enhancing Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Cognition-Enhancing Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Cognition-Enhancing Drugs Sales Market Share, 2018-2029
Figure 23. US Cognition-Enhancing Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Cognition-Enhancing Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Cognition-Enhancing Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Cognition-Enhancing Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Cognition-Enhancing Drugs Sales Market Share, 2018-2029
Figure 28. Germany Cognition-Enhancing Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Cognition-Enhancing Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Cognition-Enhancing Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Cognition-Enhancing Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Cognition-Enhancing Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Cognition-Enhancing Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Cognition-Enhancing Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Cognition-Enhancing Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Cognition-Enhancing Drugs Sales Market Share, 2018-2029
Figure 37. China Cognition-Enhancing Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Cognition-Enhancing Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Cognition-Enhancing Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Cognition-Enhancing Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Cognition-Enhancing Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Cognition-Enhancing Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Cognition-Enhancing Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Cognition-Enhancing Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Cognition-Enhancing Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Cognition-Enhancing Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Cognition-Enhancing Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Cognition-Enhancing Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Cognition-Enhancing Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Cognition-Enhancing Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Cognition-Enhancing Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Cognition-Enhancing Drugs Production Capacity (K MT), 2018-2029
Figure 53. The Percentage of Production Cognition-Enhancing Drugs by Region, 2022 VS 2029
Figure 54. Cognition-Enhancing Drugs Industry Value Chain
Figure 55. Marketing Channels
